MUMBAI: In the ongoing battle between pharma firm Cipla and the Government on alleged overpricing of drugs, the homegrown drug-maker on Monday said that it has been asked to pay Rs. 62.85 crore by price regulator National Pharmaceutical Pricing Authority (NPPA).